Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT05836272

Early Administration of Norepinephrine in Sepsis

Led by Tunis University · Updated on 2024-12-04

200

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The management of septic states includes, in addition to the specific treatment (antimicrobials and eradication of the source), a restoration of the hemodynamic disorders and assistance of the failing organs. In general, the restoration of hemodynamic disorders begins first with volume expansion, followed by the use of Noepinephrine (NE) when the target mean arterial pressure (MAP) is not reached after optimizing the intravascular volume. Recently, several studies have supported the interest of early NE on MAP, cardiac output and mortality. It is therefore tempting to restrict fluid administration even in the initial phase of hemodynamic management of severe sepsis by starting NE earlier.

CONDITIONS

Official Title

Early Administration of Norepinephrine in Sepsis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 or older
  • Patient or legal representative has given written informed consent
  • Diagnosis of sepsis according to updated sepsis 3 consensus definitions
  • Mean arterial pressure less than 65 mmHg
Not Eligible

You will not qualify if you...

  • Diagnosis of septic shock prior to randomization with norepinephrine requirements exceeding trial protocol
  • Pregnancy
  • Need for immediate surgery
  • Advanced stage cancer (neoplasia)
  • Conditions requiring water restriction such as acute pulmonary edema
  • Acute coronary syndrome

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

intensive care unit of the University Hospital Center La Rabta

Tunis, Tunisia, 1007

Actively Recruiting

Loading map...

Research Team

A

Ahlem Trifi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here